Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 548
- 试验地点
- 18
- 主要终点
- Effectiveness
研究概览
简要总结
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
详细描述
Using a step-wedge design, we will conduct a Type 2 hybrid implementation trial to assess the extent to which PNEP uptake is improved over 24 months of observation using the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy bundle. Nine prisons were non-randomly* allocated to one of three groups, with the groups receiving the intervention (i.e., NIATx) over 24 months at staggered time intervals (every 6 months). This will be followed by an additional 12 month post-intervention period, when sustainability will be assessed.
*Originally randomized; allocation was modified due to logistical constraints
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Sequential
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All people incarcerated at a study site during the intervention period
排除标准
- •- None (site level intervention)
结局指标
主要结局
Effectiveness
时间窗: From start to end of intervention period (24 months)
Number of participants on the PNEP
Effectiveness
时间窗: From start to end of intervention period (24 months)
Number of participants on the PNEP
次要结局
- Bloodborne virus cascade of care(From start to end of intervention period (24 months))
- Enrollment in opioid agonist therapy(From start to end of intervention period (24 months))
- Bloodborne virus cascade of care(From start to end of intervention period (24 months))
- Enrollment in opioid agonist therapy(From start to end of intervention period (24 months))
研究者
Nadine Kronfli
Nominated Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre